Special items: Ovarian Cancer and Us blog best viewed in Firefox

▼
Showing posts with label biomarkers. Show all posts
Showing posts with label biomarkers. Show all posts
Thursday, May 17, 2012

paywalled: Two-marker Combinations for Preoperative Discrimination of Benign and Malignant Ovarian Masses

›
Two-marker Combinations for Preoperative Discrimination of Benign and Malignant Ovarian Masses Abstract Background:  When caring fo...
Wednesday, May 16, 2012

paywalled: Differential diagnosis of a pelvic mass: improved algorithms and novel biomarkers.

›
Differential diagnosis of a pelvic mass: improved algorithms and novel biomarkers. : ABSTRACT: More than 200,000 women undergo explo...
Monday, May 14, 2012

ESO: e-grandround May 24th: Biomarkers and candidate therapeutics in ovarian cancer pipeline

›
Biomarkers and candidate therapeutics in ovarian cancer pipeline European School Oncology Online educational resources ESO ...

An In Vitro Diagnostic Multivariate Index Assay (IVDMIA) for Ovarian Cancer: Harvesting the Power of Multiple Biomarkers (OVA1)

›
An In Vitro Diagnostic Multivariate Index Assay (IVDMIA) for Ovarian Cancer: Harvesting the Power of Multiple Biomarkers Dr. Zhang is the ...
Wednesday, May 09, 2012

Myriad RBM Announces the Launch of OncologyMAP® v. 2.0

›
Myriad RBM Announces the Launch of OncologyMAP® v. 2.0 Myriad Genetics (NASDAQ: MYGN) announced today that Myriad RBM, a wholly owned sub...

paywalled: Physical Activity, Biomarkers, and Disease Outcomes in Cancer Survivors: A Systematic Review

›
Physical Activity, Biomarkers, and Disease Outcomes in Cancer Survivors: A Systematic Review : Background Cancer survivors often seek inf...
Monday, April 30, 2012

Journal of Experimental & Clinical Cancer Research | Abstract | Circulating microRNAs in cancer: origin, function and application

›
Journal of Experimental & Clinical Cancer Research | Abstract | Circulating microRNAs in cancer: origin, function and application ...
Thursday, April 26, 2012

paywalled: Role of HE4, CA72.4, and CA125 in monitoring ovarian cancer.

›
Role of HE4, CA72.4, and CA125 in monitoring ovarian cancer . Abstract The aim of this study was to investigate the role of biomark...
Wednesday, April 25, 2012

paywalled: Targeting the DNA damage response in oncology: past, presen... : Current Opinion in Oncology

›
Targeting the DNA damage response in oncology: past, presen... : Current Opinion in Oncology Current Opinion in Oncology: May 2012...
Monday, April 16, 2012

press release: (OVA1) Vermillion Receives Notice of Allowance for Patent of Biomarker for Ovarian Cancer

›
Vermillion Receives Notice of Allowance for Patent of Biomarker for Ovarian Cancer (press release) About OVA1 ...
Wednesday, April 11, 2012

Clinical trial designs for testing biomarker-based personalized therapies

›
Clinical trial designs for testing biomarker-based personalized therapies Abstract: Background Advance...
Monday, April 09, 2012

Abstract - Biotargets of Cancer in Current Clinical Practice - Ovarian Cancer

›
  Medicine Biotargets of Cancer in Current Clinical Practice Current Clinical Pathology , ...

Optimizing Molecular-Targeted Therapies in Ovarian Cancer: The Renewed Surge of Interest in Ovarian Cancer Biomarkers and Cell Signaling Pathways : Table 1 (eg. HE4....)

›
Blogger's Note: the table includes biomarkers for ovarian cancer in research Optimizing Molecular-Targeted Therapies in Ovarian Cance...

Blogger's Opinion: repost (2011) : Proteomic biomarkers in combination with CA 125 for detection of epithelial ovarian cancer using prediagnostic serum samples from the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial - Moore - 2011 - Cancer - Wiley Online Library

›
Blogger's Note/Opinion:   efforts to improve on the existing CA125 biomarkers remain elusive, as we speak;  this may be confirmed by th...
1 comment:
Tuesday, March 27, 2012

Future Medicine - Biomarkers in Medicine - numerous items of interest

›
Future Medicine - Biomarkers in Medicine  eg.: Use of molecular diagnostic tests for peripheral neuropathy called into question No...
Thursday, March 22, 2012

Marker of DNA Damage Could Predict Response to Platinum Chemotherapy

›
Marker of DNA Damage Could Predict Response to Platinum Chemotherapy : Assay could direct treatment options for triple-negative br...
Tuesday, March 20, 2012

abstract: Requirements to Assess Feasibility of Phase 0 Trials during Major Abdominal Surgery - Variability of Poly (ADP-Ribose) Polymerase Activity.

›
Wiki:  Poly ADP ribose polymerase: Poly (ADP-ribose) polymerase ( PARP ) is a family of proteins involved in a number of cellular proce...
Thursday, March 15, 2012

abstract: Impact of Preanalytic Factors on the Design and Application of Integral Biomarkers

›
Impact of Preanalytic Factors on the Design and Application of Integral Biomarkers : Molecular assays have been routinely applied to impro...

abstract: Leveling the Playing Field: Bringing Development of Biomarkers and Molecular Diagnostics up to the Standards for Drug Development

›
Leveling the Playing Field: Bringing Development of Biomarkers and Molecular Diagnostics up to the Standards for Drug Development  "....
Sunday, March 11, 2012

abstract: Evaluation of ovarian cancer remission markers HE4, MMP7 and Mesothelin by comparison to the established marker CA125 (includes graphic/study of 23 patients)

›
 Highlights (in study of 23 patients) ► Three new markers were compared to CA125 for lead time to ovarian cancer recurrence. ► HE4 elevat...